Dalmy Iskandar
Universitas Prima Indonesia

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Interleukin 6 Serum Level Between Menopausal Woman and Reproductive Woman Dalmy Iskandar; Fidel Ganis Siregar; Syamsul A. Nasution; M. Fauzie Sahil; Binarwan Halim; Dudy Aldiansyah
Vitamin : Jurnal ilmu Kesehatan Umum Vol. 4 No. 3 (2026): July : Jurnal ilmu Kesehatan Umum
Publisher : Asosiasi Riset Ilmu Kesehatan Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61132/vitamin.v4i3.2759

Abstract

Menopause is associated with declining estrogen levels and various symptoms that may affect women's quality of life. Interleukin-6 (IL-6), a pro-inflammatory cytokine influenced by estrogen, may serve as a potential biomarker for assessing the severity of menopausal symptoms. This study aimed to compare median serum IL-6 levels between postmenopausal and reproductive-age women and examine their differences according to the severity and types of menopausal symptoms. This analytical cross-sectional study involved 80 participants, comprising 40 postmenopausal women and 40 reproductive-age women. Participants completed the Menopause Rating Scale (MRS) questionnaire, and 3 mL of venous blood was collected to measure serum IL-6 levels at Prodia Clinic Laboratory. Data were analyzed using SPSS version 17 with ANOVA or the Kruskal–Wallis test, as appropriate. The median serum IL-6 level was higher in postmenopausal women than in reproductive-age women (1.70 vs. 1.37 pg/mL), although the difference was not statistically significant (p = 0.481). However, IL-6 levels differed significantly across the severity categories of menopausal symptoms (p < 0.0001), while no significant differences were found among the types of menopausal symptoms (p = 0.088). In conclusion, serum IL-6 levels did not differ significantly between postmenopausal and reproductive-age women but varied significantly according to the severity of menopausal symptoms. Further research is needed to clarify the potential role of IL-6 as a biomarker of menopausal symptom severity.
Correlation Deoxypyridinoline Urine Level with Bone Density in Menopause Woman Dalmy Iskandar; M. Fidel Ganis Siregar; Aswar Aboet; Binarwan Halim; Sarma N Lumbanraja; Roy Yustin Simanjuntak
Vitamin : Jurnal ilmu Kesehatan Umum Vol. 4 No. 3 (2026): July : Jurnal ilmu Kesehatan Umum
Publisher : Asosiasi Riset Ilmu Kesehatan Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61132/vitamin.v4i3.2762

Abstract

This study aimed to determine the relationship between urinary deoxypyridinoline levels and bone mineral density in postmenopausal women. An analytical study with a cross-sectional design was conducted at the Department of Obstetrics and Gynecology, University of North Sumatra, Haji Adam Malik General Hospital, and Dr. Pirngadi General Hospital, Medan, from January to February 2016. The study included midwives and nurses who met the inclusion criteria. The first morning urine sample, approximately 30 mL, was collected before 10:00 a.m. to measure urinary deoxypyridinoline levels at Prodia Laboratory. Data were analyzed using Pearson’s correlation test for normally distributed data and Spearman’s correlation test for non-normally distributed data, with a significance level of p < 0.05. A total of 36 postmenopausal women participated in the study. Spearman’s correlation analysis revealed a significant negative correlation between urinary deoxypyridinoline levels and bone mineral density T-scores (r = −0.623; p < 0.05), indicating that higher urinary deoxypyridinoline levels were associated with lower bone mineral density. The correlation was classified as strong. In conclusion, urinary deoxypyridinoline levels were significantly associated with bone mineral density in postmenopausal women and may serve as a marker of bone resorption.